1. Subutex-Suboxone [prescribing information]. Columbus, Ohio:Roxane Labratories, INC,February 2015.
2. SuboxoneSublingual Film [prescribing information]. Hull, UK: Reckitt Benckiser Pharmaceuticals, April 2014.
3. Zubsolv [prescribing information]. Chadds Ford, PA: Orexo Pharmaceuticals, August 2015.
4. The Management of Substance Use Disorders Working Group. VHA/DoD Clinical practice guideline for the management of substance use disorders. v. 2.0 Available at http://www.healthquality.va.gov/sud/sud_full_601f.pdf Accessed June 20, 2013.
5. Johnson RE, Jaffe JH, Fundala PJ. A controlled trial of buprenorphine treatment for opioid dependence. JAMA. 1992;267(20):2750-2755.
6. Ling W, Charuvastra C, Collins JF, et al. Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction.1998;93(4):475-486.
7. Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration; 2004. Available at: http://buprenorphine.samhsa.gov/Bup_Guidelines. Accessed June 20, 2013.
8. Mattick RP, Ali R, White J, O'Brien S, Wolk S, Danz C. Buprenorphine versus methadone maintenance therapy: a randomised double-blind with 405 opioid-dependent patients. Addiction. 2003;98:441-452.
9. Micromedex R Healthcare Series [Internet database]. Greenwood Village, Colo: Thomson Healthcare. Updated periodically. Accessed June 20, 2013.
10. Clinical Pharmacology Web site. Available at: http://www.clinicalpharmacology-ip.com/default.aspx. Accessed June 24, 2014.
13. Bunavail [prescribing information]. Raleigh, NC: BioDelivery Sciences, June 2014.